UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ FORM 8-K ________________________ CURRENT REPORT Pursuant to Section 13 or 15(D) of the Securities Exchange Act of 1934 April 9, 2024 Date of report (Date of earliest event reported) ________________________ Agile Therapeutics, Inc. (Exact name of registrant as specified in its charter) ________________________ Delaware 001-36464 23-2936302 (State or other jurisdiction (Commission (IRS Employer of incorporation) ...